STUDY QUESTION: Is endometrial recurrent implantation failure (RIF) only a matter of an asynchronous (displaced) window of implantation (WOI), or could it also be a pathological (disrupted) WOI?
designated by clinical criteria have been stratified transcriptomically as 18.6% with only a displaced WOI, 53.5% with a displaced and pathological WOI, 23.3% with only a disrupted WOI, and 4.7% could be a clinical RIF with non-endometrial origin. The new RIF transcriptomic taxonomy avoids menstrual cycle timing as a confounding variable that should be controlled for, distinguishing clearly between a disrupted and a displaced WOI for precision medicine in RIF.
Introduction
A critical step in human reproduction is successful embryo implantation. The endometrium is receptive to implantation during the window of implantation (WOI), a spatially and temporally restricted phase that is complex and multifactorial, during which changes occur at the molecular, cellular and tissue levels (Harper, 1992; Wilcox et al., 1999; Murphy, 2004) . Many studies have sought to define the healthy WOI using transcriptomics, often comparing the endometrium in different endometrial phases to characterize endometrial receptivity status (Carson et al., 2002; Kao et al., 2002; Borthwick et al., 2003; Riesewijk et al., 2003; Ponnampalam et al., 2004; Mirkin et al., 2005; Punyadeera et al., 2005; Talbi et al., 2006; Haouzi et al., 2009; Díaz-Gimeno et al., 2011; Bhagwat et al., 2013; Altmäe et al., 2014 Altmäe et al., , 2017 or comparing recurrent implantation failure (RIF) patients to controls to characterize a pathological disruption of the WOI (Bersinger et al., 2008; Tapia et al., 2008; Koler et al., 2009; Altmäe et al., 2010; Koot et al., 2016; Shi et al., 2017) . Although the experimental designs were different, most studies pursued the main objective of characterizing the normal endometrium and its changes in RIF because the possible endometrial implantation failure pathology is not detected at the morphological and single molecular level (Coutifaris et al., 2004; Aghajanova et al., 2008) .
From the clinical point of view, RIF refers to the repeated failure of good quality embryo implantation; however, a universal definition of RIF has yet to be established (Coughlan et al., 2014; Timeva et al., 2014) . RIF is usually determined by taking into account two criteria: the number of good quality embryos transferred and the number of embryo transfer (ET) procedures performed with good quality embryos (Tan et al., 2005; Thornhill et al., 2005; Margalioth et al., 2006; Rinehart, 2007) . Usually, more than three implantation failures, or more than 10 embryo transferred from ovum donation of good quality embryos or euploid embryos is considered to meet the criteria for endometrial RIF. The clinical definition, however, is uncertain and depends on numerous factors. For example, in clinics where the probability of implantation with good quality embryos is more than 70%, two implantation failures could be considered as enough to evaluate endometrial factor.
Genomic medicine is providing a deeper understanding of diseases based on the massive amounts of data generated by genomic technologies. These findings inevitably necessitate the reclassification of disease states and developing a 'new taxonomy of disease' with the goal of practising more precise medicine (Mirnezami et al., 2012) especially for complex and multifactorial traits like RIF and endometrial factor evaluation. Endometrial transcriptomic predictors to evaluate the human WOI and RIF pathology have been applied in two studies (Díaz-Gimeno et al., 2011; Koot et al., 2016) . Both works provide a signature of gene expression with a high predictive value for RIF. Díaz-Gimeno et al. (2011 , 2017 ) determined a transcriptional signature that has been demonstrated to be a powerful tool for endometrial dating in the secretory phase mirroring the WOI. This signature was also used to demonstrate that RIF originates from the asynchrony between the embryo and the endometrium due to a displacement of WOI timing (Ruiz-Alonso et al., 2013 . In contrast, Koot et al. (2016) considers endometrial RIF to be a result of both a displacement and a pathologically disrupted WOI, independent of displacements. The question, therefore, remains as to whether endometrial RIF is only a displacement, as demonstrated by Simon's group (Valdes et al., 2017) , or whether it could also be the result of molecular pathology in an otherwise on-time WOI (Macklon, 2017) .
Our objective is to demonstrate that RIF originates from at least two molecular phenomena: displaced and disrupted WOIs. As the nobel prize winner William Lawrence Bragg said 'The important thing in science is not so much to obtain new facts as to discover new ways of thinking about them.', and based on this phylosophy a comparative transcriptomic prediction in the same sample cohort between different endometrial signatures was performed. We will determine the predictive behaviour of gene transcription to distinguish between RIF causes to analyse if they are the same molecular phenomenon or are different. This results will serve to close the gap between the two hypotheses suggested in the literature (Macklon, 2017; Valdes et al., 2017) .
With these findings, we propose a new RIF taxonomy for the practise of precision medicine in endometrial factor evaluation, future research and the development of effective treatments.
Materials and Methods
Sample collection and microarray pre-processing Expression data from 115 samples (control, n = 72 and RIF, n = 43) were obtained from the gene expression omnibus (GEO) database (Edgar, 2002) . For these already published data (Koot et al., 2016) , samples were collected during the WOI from LH + 5 to LH + 8 as determined by urine testing monitored at home with an LH ovulation predictor kit (Ovulady, Clindia Benelux, The Netherlands). RIF was clinically designated by the absence of implantation after four or more transfers of high quality embryos or after the placement of 10 or more embryos in multiple transfers. RIF versus control populations were homogeneous and comparable in terms of age, BMI, smoking habits and primary infertility and significantly different in terms of treatment history before biopsy (implantation rate). Normalized data are accessible in the National Centre for Biotechnology Information GEO database, accession GSE58144. Koot et al. (2016) reported a technical batch effect related to the batchwise processing of samples, and other minor batch effect related to the medical centre where the biopsy was collected. These technical batch effects remained in the normalized data available at GEO. The batch effect related to the processing of samples has been also corrected in the present work using linear models provided by limma R-package (Ritchie et al., 2015) as was done by Koot et al. This type of correction fits a linear model to the data, removing the data for behaviour related to batches (menstrual cycle timing) and retaining the data related to the research conditions (Control/RIF). The minor batch effect related to the medical centre was not removed as Koot et al. (2016) indicated because the number of samples affected was too small.
Signature selection
Representative primary papers reporting endometrial gene signatures were selected from review articles related to WOI endometrial transcriptomics (Aghajanova et al., 2008; Haouzi et al., 2012; Koot et al., 2012; Ruiz-Alonso et al., 2012; Díaz-Gimeno et al., 2014) . RIF-related transcriptomic signatures were also obtained (Shi et al., 2017) . The signatures reviewed in those publications were obtained from the original publications, which used different criteria to select genes associated with receptivity or RIF, including differential gene expression analysis, meta-analysis, literature search or signature discovery using predictive models. All signatures were annotated using the Entrez gene code converted to gene symbol using R software (R core team, 2014) with the biomaRt R-package (Durinck et al., 2009 ). These gene signatures were then characterized.
Random signatures
As previously reported, gene signature prediction capability is affected by the signature size-the predictive value (accuracy) of the signature is increased in relation to the signature size, although this accuracy declines slightly when the signature size reaches a saturation point (Mitra et al., 2002) . To evaluate the meaning of the gene content and the size effect of each signature for prediction performance, 10 random signature subsets for each size were generated with a replacement model using the R function sample included in R (R core team, 2014 ) that takes a sample of a specific size from a given set of elements for different sample sizes: 10, 20, 50, 100, 200, 300, 500 and 700, representing the variability of sizes found in the selected signatures.
Prediction models
Transcriptomics predictors, using each selected signature as cores, were used to analyse both molecular disruption and displacement. All models were applied using the caret (Kuhn, 2015) R-package by selecting the model with the highest accuracy from a cross-validation process (10-fold), where, on each fold, 80% of samples were used as a training set and the 20% remaining were used as a test set.
Accuracy and Kappa statistics were estimated and compared between signatures. Accuracy represents the percentage of samples that the model predicts correctly in the cross-validation procedure and is widely used to compare classification results. The Kappa statistic corrects the effect of unbalanced datasets, giving a normalized prediction result. Both prediction parameters were selected because they are simple, easy to interpret, and could be comparable in a supervised classification with more than two classes.
Transcriptomic predictors were designed to detect menstrual cycle timing (displaced WOI) and a disrupted transcriptomic profile (pathological WOI). The predictive value in absolute terms for each signature was not important in these prediction designs; the relevant aspect was the comparison among signatures for prediction capability in the same sample cohort for both RIF causes analysed to test our hypothesis. Our proposed model will allow us to contrast the diagnostic possibilities resulting from the combination of both RIF causes, displacement and disruptions, in a new transcriptomic RIF taxonomy.
Transcriptomic predictors to demonstrate both RIF causes are depicted schematically in Supplementary Fig. S1 .
Displacement model design: WOI transcriptomic profiles related to menstrual cycle timing
First, a non-supervised classification of samples (n = 115) was performed using K-means analysis in R environment. The silhouette method (Rousseeuw, 1987) , which selects the number of clusters that maximizes the distance between clusters, was implemented for determining the optimal number of clusters for WOI stratification using the whole transcriptome. Once samples were classified in these groups, a kNN model (Altman, 1992) supervised by them was built for each of the signatures considered. The predictive power of each signature to classify the WOI transcriptomic profiles was compared as a metric of how signatures are able to detect potential displacements ( Supplementary Fig. S1A ).
Although it has been reported that endometrial transcriptomics, based on the first component of principal component analysis (PCA), indicates menstrual cycle timing (Talbi et al., 2006; Horcajadas et al., 2007; Ruiz-Alonso et al., 2013; Díaz-Gimeno et al., 2017) , the ability to detect the displacement effect with our prediction design was checked in our study. The comparison between these WOI profiles and the proportion of LH surge day samples from LH + 5 to LH + 8 inside each transcriptomic profile was analysed.
Pathological model design (endometrial disruption)
Two methodological approaches were used to perform the pathological disruption prediction removing the menstrual cycle timing effect and therefore excluding displacements: first, by correcting for menstrual cycle timing by LH surge differences and second correcting by transcriptomic clusters. Both methods of correction were implemented and compared using linear models included in the limma R-package (Ritchie et al., 2015) .
The removal of the menstrual cycle timing effect based on LH was the methodology used by Koot et al. (2016) to perform a signature that was not affected by the WOI timing as a confounding variable. The second methodology for removing the menstrual cycle timing effect was the WOI time effect correction from a transcriptomics point of view using the transcriptomic clusters defined after K-means unsupervised classification implemented in the displacement model design of this work (Supplementary Fig. S1B ).
The best methodology for correcting menstrual cycle timing was used for building the pathological model as follows: Support Vector Machine (SVM) models for each signature, with Radial Basis Function Kernel (Vert et al., 2004) , were modelled to distinguish between control (n = 72) and RIF (n = 43) samples, considering RIF as positive class (Supplementary Fig. S1B ).
Transcriptomics RIF taxonomy
The new transcriptomic taxonomy considers both RIF causes, disruption and displacement, as independent phenotypes that could act alone or together in the RIF etiology of the patient. Samples were classified through displacement and disruption prediction models. The displacement predictor was built using the Diaz-Gimeno model of displacement signature (Díaz-Gimeno et al., 2011) for its demonstrated prediction among menstrual cycle timing (Díaz-Gimeno et al., 2017) , and the pathologic predictor was built using the Koot model of a disruption signature (Koot et al., 2016) as the best predictor of disrupted WOIs. These signatures were used as the gold standard to perform the new transcriptomics RIF taxonomy. Molecular RIF phenotype proportions for displacement and pathology were calculated and compared between RIF and control populations, as defined by clinical criteria, using Fisher's exact test included in R core.
Functional analysis
Signature genes were annotated to functions in two manually downloaded functional databases: Gene Ontology (GO) (Ashburner et al., 2000) (release 1.2/2017-03-31) and Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et al., 2012 ) (Release 81.0) using R environment. GO term annotations were previously propagated separately for each GO ontology: biological process, molecular function and cellular component. Functions associated with each signature were compared in terms of their ability to predict both RIF causes. Genes and their functions were intersected between signatures and a functional concordance, Cohen's Kappa index (Cohen, 1960) , was calculated between signatures to determine their similarity in functional terms.
Results

Gene signatures
Sixteen signatures were selected as representative biomarkers of endometrial receptivity and considered for analysis. The specific experimental design for gene selection and sample cohort origin is described in Table I . All the signatures were representative of the transcriptomics of endometrial receptivity in controls and/or implantation failure patients.
Predictive model design for displaced and disrupted WOIs
The predictive model design for WOI timing detection identified three transcriptomic clusters: early receptive, receptive, and late receptive ( Supplementary Fig. S2A-C) . The post LH surge day (5-8) compared to the transcriptomic cluster indicated that the transcriptomic profile was related to the menstrual cycle progression as expected and as a reinforcement that the model predicts the capability of detecting displacements ( Supplementary Fig. S2B and C) . In the pathological model, the pre-processing step for the removal of menstrual cycle timing was compared between using LH or transcriptomic clusters as criteria. The transcriptomic stratification was selected as the best methodology for timing effect removal because most signatures had better accuracy when corrected by WOI transcriptomics than by LH surge. A detailed comparison is shown in Supplementary Fig. S3 .
What molecular causes of RIF are predicting the signatures?
The predictive ability of signatures in detecting WOI timing showed that all of them distinguished this endometrial phenotype with very good accuracy. The minimum accuracy was 0.85 for the Koot signature (Fig. 1A) . Eleven signatures (Kao, Riesewijk, Borthwick, Mirkin, Punyadeera, Talbi, Carrascosa, Diaz-Gimeno, Bhagwat, Bersinger and Altmäe2017) gave higher values for predicting timing than expected by chance, while only one (Koot) was lower than expected by chance (Fig. 1A) . The predictive capability for disrupted RIF detection was lower in general and less than expected by chance; only Koot and Altmäe2010 showed a predictive value higher than expected by chance (Fig. 1B) .
The ability to predict both RIF causes for each signature showed three predictive behaviours ( Fig. 2A) : signatures with a good predictive value in disruption but a worse predictive value in displacement (Koot); a group that had good prediction power for displacement and worse for disruption (represented by Kao, Mirkin Diaz-Gimeno, Bersinger, Borthwick, Bhagwat, Riesewijk, Carrascosa, Talbi and Altmäe2017) ; and finally, a group that had good predictive value for both causes, represented by the Altmäe2010, Punyadeera, Carson, and Ponnampalam signatures.
Functional relationship between signatures
The signatures differed in terms of gene intersections and functional concordance ( Supplementary Fig. S4 ). A maximum of 102 genes were shared between Diaz-Gimeno and Riesewijk ( Supplementary Fig. S4A ). A moderate functional agreement was shared by some of the signatures that predicted displacement. Bhagwat and Riesewijk showed the highest moderate agreement, with a Kappa index of 0.548 in KEGG pathways ( Supplementary Fig. S4B ), and Diaz-Gimeno and Bhagwat showed the highest moderate agreement of 0.596 Kappa index for GO biological processes (BPs) (Supplementary Fig. S4C ) and 0.58 for GO Molecular Functions (MFs) (Supplementary Fig. S4D ). The highest agreement of 0.62 for cellular components (CCs) was shown between Altmäe2017 and Borthwick ( Supplementary Fig. S4E ).
Gene content from the Koot publication differed from the other signatures, with a maximum of 12 genes shared with Carson and only one with Diaz-Gimeno. None were common among Koot, Punyadeera, or Tapia ( Supplementary Fig. S4A) . A fair functional agreement indicated a low similarity among the timing signatures. The highest fair agreements of 0.28 and 0.35 were with Borthwick for KEGG pathways ( Supplementary  Fig. S4B ) and GO BPs ( Supplementary Fig. S4C 
Ponnampalam Normally cycling women. Not use hormonal contraception in the 3 months prior tissue collection.
Histological dating EP (n = 5) MP (n = 7) LP (n = 3) ES (n = 7) MS (n = 8) LS (n = 7) Mens (n = 6)
Home made adj-P-value < 0.05 313 Ponnampalam et al.
Mirkin
Normally cycling oocyte donors. Proven fertility. Use of condom contraception during the preceding and study cycles. Fig. S4D ) and a fair agreement of 0.36 with Mirkin in GO CCs ( Supplementary Fig. S4E ) was also obtained. The relationship between functions and prediction ability for both RIF causes was analysed using the three groups of predictive behaviour found above as reference (Fig. 2A) . The detailed functional information of which GO BPs terms are annotated to each behaviour is described in Supplementary Table S2 . There were 227 functions shared by all the signatures and, as we expected, the good predictive disruption signature shared fewer functions with the signatures that predicted timing (24) than with the signatures that were good predictors of both RIF causes (75) (Fig. 2B) . In other words, the signatures that predicted both causes with good accuracy shared functions involved in both causes (Fig. 2B) .
A new RIF taxonomy
RIF classification based on clinical criteria was labelled as Koot and colleagues have defined (Koot et al., 2016) . The new molecular taxonomy considering both causes of RIF is shown in Fig. 3 . Both types of RIF could present alone or together in the same patient (Fig. 3A) . Figure 3B and C shows the contingency tables obtained from both models (disrupted and displaced) for the two clinically predefined groups of samples: control and RIF. Molecular WOI displacements presented with the same proportion in the infertile control population as in patients with RIF (Pvalue = 0.8346), while the pathological molecular cause was higher in clinically designated RIF patients (P-value = 1.51 × E-11) (Fig. 3C) . In this new RIF taxonomy, RIF patients designated by clinical criteria have been stratified transcriptomically as 18.6% with only a displaced WOI, 53.5% with a displaced and pathological WOI, 23.3% with only a disrupted WOI, and 4.7% could be a clinical RIF with non-endometrial origin.
Based on the predictive behaviour of WOI signatures demonstrated here, the molecular causes of RIF are different and could exist independently. However, both causes can also be associated, as they share functions in the WOI and can coexist in the same patient.
Discussion
Our findings demonstrate that RIF originates from at least two molecular phenomena: molecular displacements and molecular disruptions. Asynchrony (displacement) and pathology (disruption) are both possible in RIF. This information serves to close the gap between the two hypotheses suggested in the literature (Macklon, 2017; Valdes et al., 2017) .
A possible bias in the study related to the different selection criteria and other sources of variation between signatures has been resolved in this work by, one, comparing the accuracy of all the signatures with the expression values of the same dataset and, two, comparing the signature's predictive capability with the baseline provided by random signatures normalized by size. This methodology provides a uniform way to determine whether the signatures have meaning in terms of displacement or disruption, independently of the selection criteria. This concept has been reported before: a signature is biologically relevant if its predictive capacity is higher than it can be expected by chance (Venet et al., 2011; Brulard and Chibon, 2013; Lesluyes et al., 2017) . Thus, the framework underlying this approach is: if a signature has been selected by any methodology for any condition (e.g. RIF), then it might have a condition-related meaning (biological meaning); or, if a Machine learning predictors signature discovery
Description for the signature selection study context is provided for each signature analysed. Signature name; participants in the study characteristics; endometrial dating procedure; endometrial biopsy collection period and number of samples; microarray platform used; gene selection criteria (cut-off); number of genes in each signature (No. genes) and publication reference for the study. The signatures have been named using the name of the first author followed by the year of the publication when there were more than one signature by author. This signature nomenclature is used in the Results and Discussion sections to interpret the behaviour of each signature in terms of molecular causes of recurrent implantation failure. LH + X: post LH surge X days; Abs: absolute value; FC: fold-change; adj-P-value: adjusted P-value; vs: versus; n: number of samples; Mens: menstruation; P: proliferative endometrium; EP: Early proliferative endometrium; MP: mid-proliferative endometrium; LP: late proliferative endometrium; ES: early secretory endometrium; MS, mid-secretory endometrium; LS: late secretory endometrium; d: menstrual cycle days; HRT: hormonal replacement therapy; N/A: non applicable; RIF: recurrent implantation failure; IF: implantation failure; M: miscarriage; OP: ongoing pregnancy; UI: women with unexplained infertility; C: control group; B: women with one successful IVF cycle; SF: spontaneously fertile women; RRA: Robust Rank Aggregation algorithm. PFP: proportion of false positives.
signature has not been selected for any condition (random), the signature might have no meaning with respect to the condition. Following this concept, the random signatures methodology provides a baseline of normalization of the expected accuracy by chance (without any selection criteria) that allows us to test our hypothesis about the meaning of the signatures related to displacement or disruption. The dichotomous comparison, then, is if signatures have been selected as being related to a condition or not (random), independently of the selection procedure. In addition, if a signature we selected includes false positives due to lack of statistical correction, the signature size increases, but not its biological relevance. This could be the case of the Carson signature, which did not use a corrected P-value; it showed a high accuracy for displacement (Fig. 1A) , but it matched that expected by chance, indicating that the signature did not provide biological meaning in terms of displacement.
Regarding the question of what molecular causes of RIF predicted the described signatures, we found that despite the objective of each study, some of the signatures designed for pathological RIF have only good predictive value for timing, such as Bersinger who designed a study comparing implantation failures versus ongoing pregnancies endometrial biopsies (Bersinger et al., 2008) , or have good predictive value for both, such as Altmäe2010 who designed the study for unexplained infertility versus fertile controls (Altmäe et al., 2010) . On the other hand, in the pathological prediction model, most of the signatures designed to distinguish between fertility and infertility improved their accuracy using correction by transcriptomic clusters instead of LH criteria (Koot et al., 2016) . Based on these findings, we conclude that endometrial timing is a confounding variable that has been covering up the molecular disruption effect and that the improvement of the prediction due to transcriptomic correction reveals that the transcriptomic cluster provides better criteria than LH for timing effect removal. In addition, these results reinforce previous suggestions made by us related to using transcriptomics as stratification criteria instead of post-LH day criteria in endometrium (Díaz-Gimeno et al., 2017). We are confident in the timing prediction capability of the displacement model due to the presence of concordance related to the post-LH surge day in each WOI expression profile. Additionally, the PCA behaviour of samples in component one agrees with menstrual cycle time progression (from LH + 5 to LH + 8) as has been reported previously in other works (Talbi et al., 2006; Horcajadas et al., 2008; RuizAlonso et al., 2013; Díaz-Gimeno et al., 2017) .
Endometrial timing is an inherent characteristic of the menstrual cycle that is reliably detected for most of the genes expressed in the endometrium, as well as by the random signatures reported in this work (Accuracy (ACC) > 0.9, gene size > 200 genes). Thus, endometrial timing was very well predicted for all the signatures in general, as well as by Koot in particular (Koot et al., 2016) , which was designed for removing endometrial timing (ACC = 0.85). However, endometrial pathology is more difficult to characterize as a biomarker due to its extraordinary and unknown origin, more so considering that endometrial timing is a confounding variable covering up the molecular disruption effect. In addition, Koot et al. describe RIF patients as having an endometrial quality between refractory and receptive since some patients have a better IVF implantation rate compared to those with a clear RIF expression signature. This suggests that the RIF signature is correlated with the severity of the clinical RIF phenotype (Koot et al., 2016) . This reflection, together with the heterogeneous gene expression behaviour of RIF patients in the PCA (Supplementary Fig. s3 ), leads us to conclude that this pathological signature is a complex and heterogeneous signature. The underlying pathology remains unclear: different molecular phenotypes and origins could be producing this heterogeneity.
The predictive value in absolute terms for each signature was not indicative in these models; instead, the relevant feature was the comparison between signatures for their prediction capability in the same sample cohort for both RIF causes analysed. Thus, the prediction parameters described in our study are not necessarily applicable to the general population. On the other hand, this was not a meta-analysis, but rather it included some of the most relevant signatures; other relevant signatures were not considered due to the unavailability of the gene lists (Haouzi et al., 2009; Koler et al., 2009; Shi et al., 2017) or failure to identify them in initial searches (Sigurgeirsson et al., 2016) . However, the 16 signatures analysed here were enough to demonstrate two different causes of RIF and indicate possible phenotypes in RIF patients.
Genetic and functional comparison between signatures revealed that they were not especially similar as has been reported previously (Horcajadas et al., 2008; Altmäe et al., 2017) . A predictive signature does not necessarily relate to a functional meaning, as is shown in the predictive value of random signatures. Indeed, predictive signatures selected from the same dataset can have different genes but share the same functions (Shi et al., 2010) . In the case of these signatures, the variability of experimental designs and sample cohorts have increased these differences. Even so, we identified many general functions in common and a cluster of moderate functional concordance between some of the signatures that predicted displacements. However, the functional meaning underlying these signatures remains unclear and requires deeper functional research.
Finally, from a clinical point of view, our findings lay the groundwork for stratifying RIF patients by using a combination of two transcriptomic predictors. Further studies are required to calculate a realistic prevalence of both RIF phenotypes in the patient population and the clinical meaning in terms of penetrance. The clinical algorithm we propose considering both RIF molecular origins is very relevant in reproductive medicine and changes the taxonomy of RIF. The new RIF taxonomy is meaningful for RIF diagnosis as it not only distinguishes between displacements and pathology, but also allows for the detection, investigation, stratification and treatment of RIF molecular pathology.
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